COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Thromboxane Receptor Antagonist to Improve Endothelial Cell Function (TRAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03962855
Recruitment Status : Recruiting
First Posted : May 24, 2019
Last Update Posted : June 19, 2020
American Heart Association
Cumberland Pharmaceuticals
Information provided by (Responsible Party):
Jeffrey Rade, University of Massachusetts, Worcester

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 31, 2021
Estimated Study Completion Date : January 2022